MARKET

ACIU

ACIU

AC Immune
NASDAQ
2.135
-0.055
-2.51%
Opening 13:50 06/09 EDT
OPEN
2.190
PREV CLOSE
2.190
HIGH
2.215
LOW
2.095
VOLUME
388.48K
TURNOVER
--
52 WEEK HIGH
4.000
52 WEEK LOW
1.650
MARKET CAP
217.29M
P/E (TTM)
-2.5907
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ACIU last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at ACIU last week (0525-0529)?
Weekly Report · 06/01 09:33
AC Immune Reports Positive Phase 1 Data For PET Tracer ACI-19626 In Diagnosing ALS
NASDAQ · 05/26 11:11
Weekly Report: what happened at ACIU last week (0518-0522)?
Weekly Report · 05/25 09:34
AC Immune presents new Phase 1 data on uptake of ACI-19626
TipRanks · 05/22 11:25
AC Immune Presents New Preliminary Data From Phase 1 Trial Of TDP-43 Positron Emission Tomography Tracer ACI-19626 Showing Increased Uptake In Brains Of Patients With Amyotrophic Lateral Sclerosis
Benzinga · 05/22 11:08
AC Immune Phase 1 data show higher ACI-19626 TDP-43 PET uptake in ALS brains
PUBT · 05/22 11:00
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
Barchart · 05/22 06:00
More
About ACIU
AC Immune SA is a Switzerland-based clinical-stage biopharmaceutical company. The Company focuses on precision medicine for neurodegenerative diseases. It designs, discovers and develops therapeutic, as well as diagnostic products for prevention, diagnosis and treatment of diseases caused by misfolding proteins. Its SupraAntigen and Morphomer technology platforms to create antibodies, small molecules and vaccines designed to address a broad range of neurodegenerative indications, such as Alzheimer's disease (AD). The Company's pipeline includes nine therapeutic product candidates with five in clinical trials, and three diagnostic candidates. Its lead product candidate is Crenezumab, a humanized and monoclonal anti-Abeta antibody for Alzheimer’s disease. It has collaborations with pharmaceutical companies, including Roche/Genentech, Eli Lilly, Biogen, Janssen Pharmaceuticals, Nestle Institute of Health Sciences, Life Molecular Imaging (formerly Piramal Imaging) and Essex Bio-Technology.

Webull offers AC Immune SA stock information, including NASDAQ: ACIU real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACIU stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACIU stock methods without spending real money on the virtual paper trading platform.